Shares & Derivatives
Is JMB Health (2161.HK) a Buy? Uncovering China’s Po Chai Pills Giant’s 6%  Yield
By Dividend Titan  •  October 15, 2025
At HK$2.2 billion market cap, JMB Healthcare is the powerhouse behind this century-old brand of trusted pills. If you’ve lived in Singapore, Malaysia and Hong Kong, you’ve probably heard of Po Chai Pills. These tiny brown pills in their familiar bottles line the pharmacy shelves across the regions. They’re the go-to fix when your stomach acts up or when you don’t feel good from travelling. JMB Healthcare – A dividend powerhouse built on trust and tradition At HK$2.2 billion market cap, JMB Healthcare is the powerhouse behind this century-old brand of trusted pills. It’s been quietly delivering stellar returns to shareholders. And it’s showing no signs of slowing down. Now, JMB Healthcare isn’t a typical pharmaceutical company. It’s a branded healthcare operator that knows how to turn heritage into profits. In 2021, The company spun off from Jacobson Pharma (2633.HK). This move created a “pure-play” consumer healthcare business. Currently, it focuses on household brands in the Chinese community across Guangdong...
Read the full article
By Dividend Titan
I am Willie Keng and I help business owners and boutique investment firms do one thing: I build practical, effective investment processes that grow their AUM than their business can practically handle…
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published. Required fields are marked *

*

Your Email Address will not be published
*

Read More Articles
More from thefinance